Home
>
National Drug Code (NDC)
>
Jantoven
Jantoven - 52125-446-02 - (Warfarin Sodium)
Drug Information of Jantoven
| Product NDC: | 52125-446 |
| Proprietary Name: | Jantoven |
| Non Proprietary Name: | Warfarin Sodium |
| Active Ingredient(s): | 7.5 mg/1 & nbsp; Warfarin Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Jantoven
| Product NDC: | 52125-446 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040416 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130516 |
Package Information of Jantoven
| Package NDC: | 52125-446-02 |
| Package Description: | 30 TABLET in 1 BLISTER PACK (52125-446-02) |
NDC Information of Jantoven
| NDC Code | 52125-446-02 |
| Proprietary Name | Jantoven |
| Package Description | 30 TABLET in 1 BLISTER PACK (52125-446-02) |
| Product NDC | 52125-446 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Warfarin Sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130516 |
| Marketing Category Name | ANDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | WARFARIN SODIUM |
| Strength Number | 7.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Vitamin K Antagonist [EPC],Vitamin K Inhibitors [MoA] |
